Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare Biotechnology
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd > It’s on management to grow shareholder value
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(41)
•••
Post by JAKPUG4LIFEon Apr 03, 2023 10:46am
134 Views
Post# 35376080

Re:It’s on management to grow shareholder value

Re:It’s on management to grow shareholder value

These are their compensation totals for just the last 3 years. I doubt if it goes to zero it would hurt them. The normal investor though will always lose


Salary Bonus and Stock Awards for the last 3 Years...WoW

These are for the top 3 boys:

Anthony Durkacz : 2022 total $692,813.25......almost $900000 the previous year and  almost 700000 the year before that

Zeeshan Saeed: 2022: 773,989.23, 2021: 1,003,068.73  2020: 899,498.66

Donal Carroll: 2023: 732,041.68.....2021:  1,212,653.02.....2020: 623,376.11




Post by DavidRosenbergon Apr 03, 2023 6:40am
 

It’s on management to grow shareholder value

If stock goes to $0 then any shares or rewards also go to zero 

I trust they equally want to see the company succeed 

How much was dedicated towards clinical trials $ or the start of it ?

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities